Sanofi informs you about the new risk of developing regurgitation / heart valve failure associated with the use of fluoroquinolones for systemic and inhalation use.
MoreSanofi, in agreement with the Pharmacological Committee of the State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment, informs you of the following important data regarding the use of Plaquenil (hydroxychloroquine).
MoreThe main principles of combating corruption are: legality; priority of the rights, freedoms and legitimate interests of citizens; openness and transparency; consistency; interaction between the state and civil society; priority of measures to prevent corruption; inevitability of responsibility.
MoreIn connection with the announcement of the coronavirus pandemic (COVID-19) by the World Health Organization, today extensive work is being done to prevent the spread of this dangerous infection in the country.
MorePursuant to the Decree of the President of the Republic of Uzbekistan dated 23.04.19 No. PP-4297, the SUE "DVTBTTESDM" informs all interested parties.
MoreInformation on the decision to suspend the Registration Certificate for products containing fenspiride.
MoreTramadol and zopiclone ("sonnat") were included in the lists of narcotic and psychotropic drugs restricted in circulation.
MoreIn pursuance of the Resolution of the Cabinet of Ministers of the Republic of Uzbekistan No. 993 dated December 18, 2017, the Agency for the Development of the Pharmaceutical Industry developed the standards "Good Manufacturing Practice - GMP" and "Good Distribution Practice - GDP".
MoreWhat are Smart Medicine and Unified Health Data Center? What principles do they work on?
MoreIn the Republican Specialized Scientific and Practical Cardiology Center, a new three-storey building was commissioned, erected at the level of world standards and equipped with modern medical technologies.
More